body
Smell Sensitivity Improvement
Smell Sensitivity Improvement refers to a change in how readily a person notices or detects odors. It concerns the sensitivity of the sense of smell itself, rather than whether a particular smell is pleasant, unpleasant, familiar, or accurately identified.
Smell Sensitivity Improvement describes a body-related outcome tracked for wellness reference.
These are research findings, not promises. Most options have little evidence, and results differ from person to person.
What may help
None of these options has good evidence yet. Best evidence first.
2 options:1 mixed1 not enough evidence
Nasal Irrigation (Neti Pot)practiceMixed resultsSize of effect: Small
Studies disagree: some found a benefit, others found none. Do not count on it.
5 of 7 studies found a benefit; 2 found none. Strongest study: a randomized controlled trial.
A pooled review reported smell or taste disorders in 11% compared with 40% of controls. In a separate randomized trial of 90 people, hyposmia improved with IEI 30.
Open the Nasal Irrigation (Neti Pot) pageRed Light Therapy (Photobiomodulation)practiceNot enough evidence
Too few or too small studies to know if it works.
The one study found a benefit. Strongest study: a systematic review of studies.
In a study involving 7 people, 2 showed objective improvement from total anosmia to severe microsmia.
Open the Red Light Therapy (Photobiomodulation) page
The expert view shows every study, dose protocol and source.
What may help
Linked to improving it2 listedStart here
Most likely to help, from the evidence we have
- →PracticesNasal Irrigation (Neti Pot)CertaintyMediumSourceRCTSmall effect7 other sources
A pooled review reported smell or taste disorders in 11% compared with 40% of controls. In a separate randomized trial of 90 people, hyposmia improved with IEI 30.
How big is the effect
Small effectA small but noticeable difference on average.
Who was studied
- People with a condition
- Allergies
- Common Cold
- Covid 19
- Sinusitis
Open Nasal Irrigation (Neti Pot)Study result
11% developed smell/taste disorders, vs. 40% among controls (p < 0.001)
Low probability(1)
- →PracticesRed Light Therapy (Photobiomodulation)CertaintyLowSourceClinical1 other source
In a study involving 7 people, 2 showed objective improvement from total anosmia to severe microsmia.
Who was studied
- People with a condition
- Alzheimers Disease
- Cancer
- Parkinsons Disease
Open Red Light Therapy (Photobiomodulation)Study result
Two participants showed objective improvement from total anosmia to severe microsmia.
Practices compared
Practices with at least one trial of their own for this goal. Ranked by how sure the evidence is, then effect size.| Practice | How sure | Effect size | Own trials | What worked in trials |
|---|---|---|---|---|
| Nasal Irrigation (Neti Pot) | CertaintyMediumSourceRCT | Small effect | 3 trials or pooled analyses | 14×/week · 13–20 weeks |
| Red Light Therapy (Photobiomodulation) | CertaintyLowSourceClinical | 1 trial or pooled analysis |
What worked in trials: From the smallest to the typical amount in the trials that found this benefit. Not the most anyone did, not a target and not a limit.
How to read the evidence
Evidence tier — overall strength of the evidence for the whole compound
- StrongWell established — backed by strong, consistent human research.
- ModerateSome genuine support, but mostly from small or lower-quality studies. Promising, not proven.
- PreliminaryEarly-stage evidence — a promising hypothesis, not an established effect yet.
- LimitedVery limited evidence — treat this as a hypothesis, not proof.
- InsufficientNot enough good evidence to draw conclusions yet.
Certainty — how sure we can be that the effect is real
- Very highVery sure — strong, consistent evidence
- HighFairly sure — consistent evidence from good studies
- MediumModerately sure — new studies could change this
- LowNot sure — little or mixed evidence
- Very lowVery unsure — almost no usable evidence
Source — where the data comes from
- Meta-analysisPooled analysis of many trials — the strongest evidence
- RCTRandomized controlled trial — a strong human study design
- ClinicalA human clinical study
- Reference knowledgeFrom general health-science or pharmacology references, not a study of this exact claim
- Animal researchStudied in animals, not humans
- Community reportsAggregated user reports — anecdotal signal, not evidence
- TheoreticalMechanism-based reasoning, not yet tested
Study grade — quality of each underlying study (A best, D weakest)
- AHigh-quality — strong, consistent human trials
- BGood — solid evidence with some limitations
- CModerate — limited, small, or mixed-quality studies
- DWeak — preliminary, indirect, or animal-only
Confidence — how strongly the sources back a finding
A 0–100 score from study quality and agreement
Most supplement evidence is graded C–D. Read it as preliminary signal, not proof.
Full write-up
What is it
Smell Sensitivity Improvement refers to a change in how readily a person notices or detects odors. It concerns the sensitivity of the sense of smell itself, rather than whether a particular smell is pleasant, unpleasant, familiar, or accurately identified. This is a body-related outcome, not an adverse effect.
How interventions help
Resveratrol and Zinc are both described as potentially improving smell sensitivity, but the available information does not establish a clinical intervention pattern for either one. The observations come from informal reports rather than human research, and the health status of the people making those reports was not specified. This limits how confidently the experience can be applied to people with a particular cause or condition affecting smell.
The two interventions also differ in the timing described. Zinc is associated with an immediate onset category, suggesting that reported changes were noticed without a prolonged lead-in period. Resveratrol has no stated onset information, so it is not possible to say how quickly any change might appear. Neither intervention is identified as requiring daily use, and there is no information about dose, duration, or whether any change persists after stopping. These gaps mean the reports describe possible experiences rather than a defined schedule or expected course of improvement.
Choosing guidance
Neither Resveratrol nor Zinc has human evidence establishing that it improves smell sensitivity. The support for both options is anecdotal, so it should not be treated as confirmation that either option causes this change. The health status of the people represented is also unspecified, which limits how confidently these observations can be applied to any particular person.
There is no dose or duration information here to guide selection, and no basis for comparing the options on effectiveness. Zinc is the only option with an onset characterization, but that does not establish how consistently the effect occurs or whether it applies across different causes of reduced smell. These options may therefore be of interest when reviewing anecdotal possibilities, but neither is clearly suited to a defined group, and the available information does not support choosing one over the other.